Serum growth differentiation factor 15 trajectory predicts 28-day mortality in critically ill patients: a multicenter cohort study
PeerJ · 2025
DOI: 10.7717/peerj.20317 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift PeerJ, 2025. Verfasst von Qinxue Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Intensive Care Unit, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Growth Differentiation Factor 15, Critical Illness, Hospital Mortality. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Outstanding Youth Project of Heilongjiang Natural Science Foundation.
Abstract (Originalsprache)
Background
Growth differentiation factor 15 (GDF15) has been linked to critical illnesses, particularly cardiovascular and infectious diseases, but its dynamic patterns and prognostic value in critically ill patients remain unclear. This study investigates the predictive utility of serum GDF15 trajectories for 28-day mortality among patients in the intensive care unit (ICU).
Methods
In this multicenter, prospective cohort study, ICU patients were enrolled, and serum GDF15 trajectories during the first week were analyzed using group-based trajectory modeling (GBTM). The association between trajectory subtypes and 28-day mortality was assessed through hierarchically adjusted multivariable logistic regression. A cumulative index, “GDF15-load,” was introduced to quantify overall GDF15 exposure and compared with the Acute Physiology and Chronic Health Evaluation II (APACHE II) and Sequential Organ Failure Assessment (SOFA) scores. The correlation between initial GDF15 levels (GDF15-D1) and GDF15-load was evaluated using Spearman’s correlation test. Predictive performance was assessed via the area under the receiver operating characteristic curve (AUROC), and feature importance was interpreted using Shapley Additive Explanations (SHAP).
Results
Among 1,973 patients, 493 comprised the cohort for development with full serum profiles on days 1, 3, and 7. Four GDF15 trajectory subtypes were identified: low-maintenance (LM), medium-maintenance (MM), high-increase (HI), and high-persistent (HP). Trajectory subtypes showed significant differences in inflammatory markers, organ dysfunction, and 28-day mortality, with the HI and HP groups having the worst outcomes. GDF15-load increased progressively from LM to HP and emerged as the most important predictor of 28-day mortality, not inferior to APACHE II and SOFA scores. GDF15-D1 was strongly correlated with GDF15-load (Spearman r = 0.778) and demonstrated robust predictive value, particularly in postoperative ICU patients, where its combination with APACHE II or SOFA further improved prognostic accuracy.
Conclusions
Serum GDF15 trajectory and GDF15-load are robust predictors of 28-day mortality in ICU patients. GDF15-D1 strongly reflects cumulative GDF15 burden and provides a rapid, practical tool for early risk stratification, especially in postoperative ICU patients. These findings support the use of GDF15 as both a dynamic and point-of-care biomarker in intensive care settings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatric Intensive Care Unit, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Critical Care Center, First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Nanjing Medical University, Nanjing, Jiangsu, China.
- Department of Critical Care Medicine, Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
- Department of Critical Care Medicine, Women's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.
- Key Laboratory of Cardiovascular and Cerebrovascular Medicine, Nanjing Medical University, Nanjing, Jiangsu, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Outstanding Youth Project of Heilongjiang Natural Science Foundation
- Young Scholars Fostering Fund of the First Affiliated Hospital of Nanjing Medical University
Zitieren
APA
Wang, Q., Wang, J., Zhao, Y., Ma, Y., Li, X., Chang, X., Zheng, N., Ji, Y., & Han, Y. (2025). Serum growth differentiation factor 15 trajectory predicts 28-day mortality in critically ill patients: a multicenter cohort study. PeerJ. https://doi.org/10.7717/peerj.20317
Vancouver
Wang Q, Wang J, Zhao Y, Ma Y, Li X, Chang X, et al. Serum growth differentiation factor 15 trajectory predicts 28-day mortality in critically ill patients: a multicenter cohort study. PeerJ. 2025. doi:10.7717/peerj.20317
BibTeX
@article{Wang2025,
author = {Wang, Qinxue and Wang, Jiawei and Zhao, Yuhan and Ma, Yuanze and Li, Xiang and Chang, Xinyi and Zheng, Nan and Ji, Yong and Han, Yi},
title = {Serum growth differentiation factor 15 trajectory predicts 28-day mortality in critically ill patients: a multicenter cohort study},
journal = {PeerJ},
year = {2025},
doi = {10.7717/peerj.20317}
}
EUVIMED